Latest filing published 18 Nov 2025 for Stoke Therapeutics, Inc., €453k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Adrian R. Krainer: trading record in brief
Adrian R. Krainer discloses dealings in Stoke Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 14 November 2025 to 10 March 2026, the count stands at 5 filings.
Sales make up the whole of the open-market record (5 sales, €3.4M). In 2026 alone, the filings show no purchases and 2 sales.
The newest entry dates from 12 March 2026: an open-market sale of €1.1M, in Stoke Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Adrian R. Krainer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 19,790 shares@ US$26.6141Common StockSEC:0001780081-25-000004:0
1 of 1 declaration
